Co-Founder with 10+ years of Entrepreneurial Experience with a Talent for Innovation

During the COVID-19 Pandemic, Greg made his mark by clearing several products from Korea to the USA via Emergency Use Authorization (EUA).

He has directly remediated and obtained emergency release permits for customs holds by the US FDA and USDA, and hosted a successful virtual audit of a chemical manufacturer’s Greenseal Mark.

Greg has worked alongside Adam and Ethan for several years where he has supported projects on behalf of the team, which include the first Korean IVDR Eudamed registration for CE Mark, and ongoing support of transitioning EUA devices to 510ks.

Greg's support under the guidance of our former FDA members has given him a strong foundation in Design Controls, Quality Management Systems, Quality Assurance, and overall Design and Development of MDs/IVDs from a globally harmonized regulatory perspective.

In early 2023, he obtained mutually recognized certification identified by TransCelerate BioPharma for Clinical Trials with Investigational Drugs and Biologics (ICH Focus) - verify here.

He is also certified by the Johner Institut for completion of the MDR for Auditors course.